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Coronary Computed Tomography Angiography
Using a Semiquantitative Score
Sam J. Lehman, MBBS,* Christopher L. Schlett, BS,* Fabian Bamberg, MD, MPH,*†
Hang Lee, PHD,‡ Patrick Donnelly, MD,* Leon Shturman, MD,* Matthias F. Kriegel, BS,*
Thomas J. Brady, MD,*† Udo Hoffmann, MD, MPH*†
Boston, Massachusetts
O B J E C T I V E S We sought to describe the progression of coronary atherosclerotic plaque over time
by computed tomography (CT) angiography stratiﬁed by plaque composition and its association with
cardiovascular risk proﬁles.
B A C KG ROUND Data on the progression of atherosclerosis stratiﬁed by plaque composition with
the use of noninvasive assessment by CT are limited and hampered by high measurement variability.
METHOD S This analysis included patients who presented with acute chest pain to the emergency
department but initially showed no evidence of acute coronary syndromes. All patients underwent
contrast-enhanced 64-slice CT at baseline and after 2 years with the use of a similar protocol. CT datasets
were coregistered and assessed for the presence of calciﬁed and noncalciﬁed plaque at 1 mm cross
sections of the proximal 40 mm of each major coronary artery. Plaque progression over time and its
association with risk factors were determined. Measurement reproducibility and correlation to plaque
volume was performed in a subset of patients.
R E S U L T S We included 69 patients (mean age 55  12 years, 59% male patients) and compared 8,311
coregistered cross sections at baseline and follow-up. At baseline, any plaque, calciﬁed plaque, and
noncalciﬁed were detected in 12.5%, 10.1%, and 2.4% of cross sections per patient, respectively. There was
signiﬁcant progression in the mean number of cross sections containing any plaque (16.5  25.3 vs. 18.6 
25.5, p  0.01) and noncalciﬁed plaque (3.1  5.8 vs. 4.4  7.0, p  0.04) but not calciﬁed plaque (13.3 
23.1 vs. 14.2 22.0, p 0.2). In longitudinal regression analysis, the presence of baseline plaque, number of
cardiovascular risk factors, and smoking were independently associated with plaque progression after
adjustment for age, sex, and follow-up time interval. The semiquantitative score based on cross sections
correlated closely with plaque volume progression (r  0.75, p  0.0001) and demonstrated an excellent
intraobserver and interobserver agreement (  0.95 and   0.93, respectively).
CONC L U S I O N S Coronary plaque burden of patients with acute chest pain signiﬁcantly increases during
the course of 2 years. Progression over time is dependent on plaque composition and cardiovascular risk proﬁle.
Larger studies are needed to conﬁrm these results and to determine the effect of medical treatment on
progression. (J Am Coll Cardiol Img 2009;2:1262–70) © 2009 by the American College of Cardiology Foundation
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1263erial assessment of coronary plaque burden
has contributed to the understanding of the
natural history and pathophysiology of cor-
onary artery disease (CAD) and is a surro-
ate end point for the evaluation of novel cardio-
ascular therapeutics (1–8). Invasive modalities
uch as intravascular ultrasound (IVUS) and serial
elective coronary angiography are considered gold-
tandard methods to measure the progression of
therosclerotic plaque and stenoses over time (4).
owever, these modalities are limited by their
nvasive nature and by the specific characteristics
hey are able to measure. Noninvasively, repeated
easurements of coronary artery calcium (CAC) by
lectron-beam or multidetector computed tomog-
aphy (CT) have been used to assess changes in
AC burden. However, CAC represents only 1
omponent of atherosclerotic plaque, and follow-up
tudies (2,9–12) of CAC in which the authors
ssessed the role of both medical therapies and
ardiovascular risk factors have led to contradictory
esults. More recently, contrast-enhanced coronary
ultidetector CT has been established as a robust
nd reliable modality to noninvasively detect the
resence, extent, and composition of coronary
laque (13,14). However, the few studies available
15,16) suggest a high measurement variability of
uantitative assessment of plaque area and volume
ata.
In the present study, we determined the intraob-
erver and interobserver variability of a new semi-
uantitative method to assess the presence, extent,
nd composition of atherosclerotic plaque as de-
ected by 64-slice coronary CT angiography. This
ethod was used to assess changes in atheroscle-
otic plaque burden during the course of 2 years in
cohort of patients with acute chest pain. In
ddition, we evaluated measurement variability of
ur semiquantitative score based on cross sections
nd its correlation to plaque volume measurements.
inally, we determined whether changes in athero-
clerotic plaque burden were independently associ-
ted with traditional cardiovascular risk profiles and
orrelated this new score with change in plaque
olume in a subset of patients.
E T H O D S
atients. Patients were prospectively enrolled from
he ROMICAT (Rule Out Myocardial Infarction
sing Computer Assisted Tomography) trial, a
rospective, observational cohort study of coronary
T angiography in patients with acute chest pain fiut an inconclusive initial evaluation (negative car-
iac enzymes, nondiagnostic electrocardiography)
n the emergency department (17).
The present study was performed in consecutive
ubjects who agreed to participate in a 2-year
ollow-up. These patients were contacted by phone,
nd the return visit included a structured clinical
nterview. Subjects with a creatinine clearance of
50 ml/min or atrial fibrillation were excluded. All
ther subjects underwent repeated contrast-
nhanced coronary CT scanning (n  69). The
tudy was approved by the institutional review
oard of the Massachusetts General Hospital, and
ll subjects provided written informed consent.
oronary CT acquisition. Baseline and follow-up car-
iac CT scans were performed with the use of
4-slice scanner technology (Sensation 64, Siemens
edical Solutions, Forchheim, Germany)
nd identical acquisition protocols as de-
ailed previously (17). Axial CT images
ere reconstructed with a slice thickness of
.75 mm and increments of 0.4 mm with
etrospective electrocardiogram gating.
oronary CT image analysis. Coronary re-
onstructions blinded to patient name and
tudy date were transferred to an offline
orkstation and curved multiplanar refor-
ations generated (Circulation, Leonardo,
iemens Medical Solutions). The extent of
therosclerotic plaque burden at both base-
ine and follow-up was assessed for the
ntire left main coronary artery (LM) and
he proximal 40 mm of the left anterior
escending (LAD), left circumflex (LCX),
nd right (RCA) coronary artery on 1-mm
hick cross sections reconstructed in 1-mm
ncrements without gaps or overlaps (Fig. 1). The
roximal coronary tree was selected for analysis be-
ause these segments contain the culprit lesions in the
ajority of acute coronary syndrome presentations
nd typically have greater image quality on contrast-
nhanced CT than distal segments (18,19).
For the LCX, the larger of the true circumflex
nd the obtuse marginal artery was analyzed. To
nsure correct coregistration, the first cross section
nalyzed in any vessel was immediately distal to
ither the aorta (in the case of the LM and RCA)
r the bifurcation of the LAD and LCX (for LAD
nd LCX). The centerline of the artery was used to
dvance in 1-mm increments distally to obtain the
econd and all subsequent cross sections.
Reconstructed arteries and cross sections were
A B B
A N D
CAC
CAD
CI c
CT
CVRF
factor
FRS
IVUS
LAD
coron
LCX
artery
LM
RCArst analyzed for image quality by 2 experiR E V I A T I O N S
A C R O N YM S
coronary artery calcium
coronary artery disease
onfidence interval
computed tomography
 cardiovascular risk
s
Framingham Risk Score
 intravascular ultrasound
left anterior descending
ary artery
left circumflex coronary
left main coronary arteryenced
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1264bservers and graded as evaluable or nonevaluable. An
rtery or cross section was determined nonevaluable
hen either motion or poor contrast-to-noise ratio
endered the detection of plaque in the artery impos-
ible. Any cross section deemed nonevaluable either at
aseline or follow-up was excluded from analysis.
An experienced reader, blinded to time of scanning
baseline/follow-up), determined the presence of cal-
ified or noncalcified plaque in all evaluable cross
ections. Calcified plaque was defined by any structure
istinct from the vessel lumen within the artery wall
ith a CT attenuation of 130 Hounsfield units
HU). The presence of any calcification within the
orresponding cross section rendered the cross section
s calcified. Noncalcified plaque was defined by a
tructure assigned to the coronary artery wall with CT
ttenuation above the surrounding tissue but below
hat of the contrast enhanced lumen without any
alcified plaque being present (20).
Interobserver and intraobserver variability for
laque detection were assessed in 15 randomly
elected subjects at baseline and follow-up by 2
ndependent observers blinded to the patient iden-
ity and scan date and with a lag period of 2 weeks
Figure 1. Change in Coronary Plaque at 2-Year Follow-Up
Contrast-enhanced image of the right coronary artery is displayed (
line (B1, B2, and B3) and 2-year follow-up (C1, C2, and C3). Cross s
nary ostium. B1 and C1 demonstrate no plaque at baseline and no
and noncalciﬁed plaque at follow-up; B3 and C3 demonstrate nonc
the development of luminal obstruction (stenosis).etween the intraobserver readings. mTo compare volumetric plaque progression with
he semiquantitative score, only patients who had
laque at baseline were eligible (n  38). In
ddition, we limited our analysis to arteries with
xcellent image quality because measurements of
laque volume are more likely to be affected by
ecreased image quality than the newly defined
core; Pflederer et al. (21) demonstrated signifi-
antly increased interobserver variability for quan-
ification of coronary plaque in cases with poor
mage quality. As a result, we measured plaque
olume (in mm3) at baseline and follow-up in 34
essels (18 LAD, 10 LCX, and 6 RCA in 24
atients) by using automated software on an offline
ork-station (SUREPlaque, Vitrea 2, Vital Images,
lymouth, Minnesota). The outer vessel boundary
nd inner luminal boundary of the proximal 40 mm
f the selected coronary artery initially were auto-
atically traced and subsequently manually ad-
usted in a cross-sectional view. Pixels with attenu-
tion between 1,300 and 100 HU within the
rea between outer vessel boundary and inner lumi-
al boundary were defined as plaque.
linical covariates. At baseline, we collected infor-
ith cross sections perpendicular to the vessel centerline at base-
ons were coregistered by use of the distance from the right coro-
ue at follow-up; B2 and C2 demonstrate no plaque at baseline
ed plaque at baseline and noncalciﬁed plaque at follow-up withA) w
ecti
plaq
alciﬁation on cardiovascular risk profile for all study
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1265articipants. History of CAD was defined by
revious symptomatic CAD treated by medication
r coronary revascularization (stent placement or
oronary bypass grafting). Measurement of blood
ressure, serum lipids, and fasting blood glucose
as obtained during index presentation. Hyperten-
ion was defined by a systolic blood pressure of
140 mm Hg or diastolic pressure of 90 mm Hg
r current antihypertensive treatment. Hyperlipid-
mia was defined by a total cholesterol 200 mg/dl
r treatment with lipid-lowering medication and
iabetes by fasting blood glucose 126 mg/dl or
reatment with hypoglycemic medication. Smoking
as defined by current or previous daily cigarette
se. Family history of CAD was defined as the
ccurrence of myocardial infarction in a first-degree
elative55 years of age for men and65 years of age
or women. Statin medication was defined as ongoing
tatin treatment at baseline. The Framingham Risk
core (FRS) was calculated for each patient by use of
he established regression model (22).
tatistical analysis. Continuous measures were sum-
arized by mean  SD and categorical by percent-
ge (counts) unless otherwise specified. Accord-
ngly, the Wilcoxon signed rank test, paired t test,
nd the Fisher exact test were used to assess for
ifferences within continuous and categorical vari-
bles. Evaluation of interobserver and intraobserver
greement was performed by Kappa statistic.
Linear regression was used to determine the
mount of plaque volume contained in a single cross
ection including the 95% confidence intervals
CIs). Absolute and relative change in plaque bur-
en by use of the semiquantitative score and the
olumetric approach were determined with a Pear-
on correlation coefficient (r).
To estimate the mean plaque rate change during
he 2-year follow-up interval after adjusting for the
nown cardiovascular risk factors (CVRF), longitu-
inal linear regression models were used, which
andled the correlated outcomes within persons
easured on the baseline and follow-up by the
eneralized estimating equations approach with
dentity link function. Further, the top quartile of
laque progression was used to identify subjects
ho progressed rapidly and were compared with
emographics, statin use, and return visits to the
mergency department with the remaining cohort.
To balance specificity and sensitivity to detect
rogression, we prospectively determined that the
umber of cross sections containing plaque per
atient had to increase by at least 2 to represent
rogression. To maintain sensitivity, we performedeasurements in 1-mm increments. To maintain
pecificity, an increase of at least 2 was required.
ll performed tests were 2-sided, and a value of
 0.05 was considered as statistically significant.
E S U L T S
atients. Baseline demographics for the 69 patients
re presented in Table 1. The mean age of patients
eturning was 55 12 years, 59% were men, and 10
atients had a history of CAD (14.5%). The me-
ian FRS in the cohort was 9 (interquartile range
.5 to 11.4).
mage quality. Heart rate during the scan was not
ifferent between baseline and follow-up (63.0 
.3 beats/min vs. 62.7  7.5 beats/min, p  0.63,
espectively). There were 11 (4.0%) of 276 arteries
nd 640 (7.0%) of 9,199 cross sections that were not
valuable at baseline, and of these, 10 (90.9%) of 11
rteries and 513 (80.2%) of 640 cross sections also
ere not evaluable at follow-up. There were an
dditional 2 (0.7%) of 276 arteries and 248 (2.7%)
f 9,199 cross sections not evaluable at follow-up.
ence, among all patients a total of 13 (4.7%) of
76 arteries and 888 of (9.7%) 9,199 cross sections
ere excluded from analysis as the result of image
uality (motion or poor contrast-to-noise ratio).
Table 1. Baseline Demographics of 69 Subjects Who
Underwent Repeat 64-Slice Coronary CT Angiography
Variable Mean  SD or n/ntotal (%)
Age, yrs
Overall 55 12
45 15/69 (22)
4564 40/69 (58)
65 14/69 (20)
Male sex 41/69 (59)
Cardiovascular risk factors
Overall 1.4 1.1
0 18/69 (26)
12 39/69 (57)
3 12/69 (17)
Framingham Risk Score 9 [4.511.4]
Hypertension 31/69 (45)
Diabetes 4/69 (6)
Hyperlipidemia 37/69 (54)
Smoking 35/69 (51)
History of CAD 10/69 (15)
Family history of CAD 16/69 (23)
Time to follow-up, months 24 3
Values are presented as absolute numbers with percentages or mean  SD.
Framingham Risk Score is presented as median [interquartile range]. History
of CAD  documented history of symptomatic CAD.
CAD  coronary artery disease; CT  computed tomography.
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1266eproducibility of plaque assessment. In a subset of
5 randomly selected patients at baseline and
ollow-up (n  4,057 cross sections) the intraob-
Non-Calcified Plaque
p = 0.04
Any Plaque
p = 0.01
Calcified Plaque
p = 0.2
Progression of Coronary Atherosclerotic Plaque Burden
n of coronary atherosclerotic burden expressed as a change in the
of cross sections containing plaque between baseline and fol-
detected by 64-slice coronary computed tomography stratiﬁed by
position. Among 69 subjects, the mean number of cross sections
any plaque increased by 12.7% (16.5  25.3 vs. 18.6  25.5, p 
g a period of 24  3 months. Stratiﬁcation by plaque composi-
ed a signiﬁcant 41.9% increase in noncalciﬁed plaque (3.1  5.8
.0 cross sections containing noncalciﬁed plaque, p  0.04) but no
increase in calciﬁed plaque (13.3  23.1 vs. 14.2  22.0 cross sec-
ining calciﬁed plaque, p  0.2).
Table 2. Coronary Atherosclerotic Plaque Burden at Baseline an
as Cross Sections in Whom Plaque Was Detected
Number of Cross
Sections With Plaque
at Baseline
S
Any plaque
Per subject 16.5 25.3 (12.5)
LM 1.5 3.0 (11.6)
LAD 8.0 11.5 (20.0)
LCX 3.7 8.1 (9.3)
RCA 3.2 7.0 (8.1)
Calciﬁed plaque
Per subject 13.3 23.1 (10.1)
LM 1.1 2.6 (8.1)
LAD 6.9 10.9 (17.2)
LCX 3.1 7.3 (7.7)
RCA 2.8 6.4 (7.0)
Noncalciﬁed plaque
Per subject 3.1 5.8 (2.4)
LM 0.5 1.6 (4.3)
LAD 1.3 2.8 (3.3)
LCX 0.8 2.5 (1.9)
RCA 0.62.4 (1.6)
Values are presented as mean  SD (%) or mean (%).
LAD  left anterior descending coronary artery; LCX  left circumﬂex coronary arerver and interobserver agreement for the detection
f any plaque per cross section was excellent ( 
.95, 95% CI: 0.94 to 0.97 and   0.93, 95% CI:
.92 to 0.95, respectively). Plaque type-specific
nalysis and intraobserver and interobserver agree-
ent were excellent for the detection of calcified
 0.96, 95% CI: 0.95 to 0.97 and  0.97, 95%
I: 0.96 to 0.98, respectively) and very good for the
etection of noncalcified (  0.76, 95% CI: 0.68
o 0.83 and   0.73, 95% CI: 0.65 to 0.81,
espectively) plaque.
therosclerotic plaque burden at baseline. At base-
ine, on average 16.5  25.3 (12.5%) cross sections
ontained any atherosclerotic plaque per patient
Table 2). Calcified plaque was detected 5 times
ore frequently than noncalcified plaque (13.3 
3.1 [10.1%] and 3.1  5.8 [2.4%], respectively).
hange of atherosclerotic plaque burden over
ime. We observed a significant 12.7% increase in
he mean number of cross sections containing any
laque (16.5  25.3 vs. 18.6  25.5, p  0.01)
Table 2, Fig. 2). When stratified by plaque com-
osition, there was a significant 41.9% increase in
oncalcified plaque (3.1  5.8 vs. 4.4  7.0, p 
.04) but no significant increase in mean number of
ross sections containing calcified plaque (13.3 
3.1 vs. 14.2  22.0, p  0.2).
Year Follow-Up per Subject and Each Coronary Artery Deﬁned
mber of Cross
ons With Plaque
t Follow-Up
Absolute and
Relative Plaque
Progression p Value
.6 25.5 (14.1) 2.1 (12.7) 0.01
.2 3.7 (16.6) 0.6 (40.0) 0.005
.2 10.7 (20.5) 0.2 (2.5) 0.7
.6 9.1 (11.4) 0.8 (24.3) 0.001
.7 7.0 (9.1) 0.4 (15.6) 0.5
.2 22.0 (10.8) 0.9 (6.8) 0.2
.3 2.8 (11) 0.2 (18.2) 0.01
.9 10.4 (17.2) 0 (0) 0.9
.5 7.7 (8.7) 0.4 (12.9) 0.005
.1 6.2 (7.9) 0.7 (10.7) 0.009
.4 7.0 (3.4) 1.3 (41.9) 0.04
.9 2.1 (6.4) 0.4 (80.0) 0.07
.6 3.4 (4.0) 0.3 (23.1) 0.4
.2 3.3 (3.1) 0.9 (112.5) 0.03
.92.2 (2.1) 0.2 (33.3) 0.5Pe
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1267Overall, plaque progression (defined as 2 cross
ections containing plaque) occurred in 26 (37.7%)
f 69 subjects, no change was observed in 43
62.3%) of 69 subjects, and none of the subjects, 0
0%) of 69, demonstrated plaque regression.
mong patients in whom plaque was detected on
he baseline scan, plaque progression occurred in 20
52.6%) of 38, whereas no change was observed in
he remaining 18 (47.4%) of 38 patients.
orrelation of the semiquantitative score to progres-
ion of actual plaque volume. In a subset of 34
essels, on average 9  7 cross sections of plaque
ith a plaque volume of 100  77 mm3 at baseline
nd on average 11  8 cross sections of plaque with
plaque volume of 125  91 mm3 at follow-up
ere detected. One cross section contained an
verage plaque volume of 7.6 mm3 (95% CI:
.8 mm3 to 9.5 mm3). Absolute and relative change
n the semiquantitative score were strongly corre-
ated with absolute and relative change in plaque
olume (r  0.75, p  0.0001 and r  0.79, p 
.0001, respectively) (Fig. 3).
hange of atherosclerotic plaque burden over time
nd its association with cardiovascular risk factors and
emographics. In univariate longitudinal regression
odels age, male sex, hypertension, hyperlipidemia,
istory of CAD, number of CVRFs, FRS, the
resence of baseline plaque, and baseline statin
edication were significantly associated with pro-
ression of any atherosclerotic plaque (Fig. 4).
In models adjusted for age, sex, and the
ollow-up time interval, the presence of baseline
laque, number of CVRFs, smoking, and baseline
tatin medication were associated with increase in
laque during the follow-up period (Fig. 5).
Subjects who were in the highest quartile of
laque progression (n  17) did not differ with
espect to age, sex, and statin medication (p 0.63,
 0.39, and p  0.38, respectively) from the
emaining cohort. In contrast, subjects with rapid
rogression were more likely to return to the emer-
ency department with recurrent chest pain as
ompared with the remaining cohort (29.4% vs.
.7%, p  0.03).
I S C U S S I O N
n this study, we demonstrate a significant increase
n coronary plaque burden during a 2-year period
12.7%, p  0.01) among patients with acute chest
ain, but without acute coronary syndromes, by
sing a highly reproducible semiquantitative assess-ent of coronary plaque burden (  0.95 and  
.93 for intraobserver and interobserver agreement,
espectively). Our results further indicate that there
re differences in the rate of progression according
o plaque composition because we found no signif-
cant progression for calcified plaque whereas non-
alcified plaque progressed significantly over time
41.9%, p  0.04). Progression of plaque was
ignificantly associated with the presence of baseline
laque, smoking, statin use, and number of cardio-
ascular risk factors in adjusted analysis. Further-
ore, in a subset of vessels, we demonstrate a robust
orrelation of the absolute and relative change of
he semiquantitative score to progression of actual
laque volume (r  0.75, p  0.0001 for both).
Although feasibility of quantitative measurement of
oronary plaque volume by 16- and 64-slice CT with
he use of methodology similar to IVUS has been
reviously described in selected patients with excep-
ional image quality, the authors of these studies
15,16) found substantial interobserver variability for
he assessment of plaque volume between 16% and
7%. The lack of agreement has been related to low
ontrast resolution of CT and the resulting difficulty
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Plaque Volume
Scatter plot demonstrates the comparison of absolute plaque progr
a subset of 34 vessels as determined by the semiquantitative score
use of cross sections and plaque volume measurements. Plaque vo
mm3) was measured by the use of automated software (SUREPlaqu
2, Vital Images) and deﬁned as any pixels with an attenuation betw
1,300 and 100 HU within the area between outer vessel bound
inner luminal boundary. Pearson coefﬁcient of r  0.75, p  0.0001
cated a robust correlation between absolute change in number of
tions containing plaque and absolute change of plaque volume as
expressed as a partial regression line (solid line) plus 95% conﬁden Plaque
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1268o correctly delineate the boundaries of smaller non-
alcified plaques, and it further indicates the limited
tility of this method for progression studies. As a
esult, many investigators (23–25) have returned to
sing a qualitative description of plaque burden most
ften stratified by coronary segments.
In this study, we introduced a semiquantitative
echnique with excellent observer reliability for both
alcified and noncalcified plaque that is based on the
etection of plaque presence in consecutive cross
ections. This technique rendered a low interobserver
ariability of 0.2%, which is a prerequisite to assess
hanges in plaque burden over time. Furthermore, we
ound a good correlation between absolute and relative
hange of the new semiquantitative score with volu-
etric plaque progression (9  7 to 11  8 cross
ections containing plaque compared with 100  77
m3 to 125  91 mm3 at baseline and follow-up,
espectively, r 0.75, p 0.0001 for both). The high
oncordance indicates that the semiquantitative
pproach provides a good estimate of volumetric
rogression and that the differences as a result of
ross-sectional plaque progression (e.g., positive re-
p Interval
der (Male)
, 45-64 yr*
e, >64 yr*
ertension
Diabetes
rlipidemia
Statin Use
Smoking
ry of CAD
ry of CAD
BMI
RF (cont.)
-2 CVRF**
>2 CVRF**
RS (cont.)
-10 FRS***
10 FRS***
ne Plaque
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
0.0-0.1-0.2 0.30.20.1 0.50.4
Predictors of Plaque Progression
effect sizes of covariates in univariable longitudinal regression
mean plaque progression over the course of 24  3 months.
plot displays estimated effect sizes of regression coefﬁcients with
ence intervals (x-axis). Covariates associated with a signiﬁcant
plaque at 2 years were male sex, age as a continuous (cont.) and
l variable, hypertension, hyperlipidemia, history of coronary artery
D), presence of baseline plaque, number of cardiovascular risk
RF), and the Framingham risk score (FRS) as a continuous variable
ars of age, as compared to patients younger than 45 years;
of positive cardiovascular risk factors (hypertension, hyperlipid-
etes, smoking, and family history of coronary artery disease, as
to patients with no CVRF); ***FRS at baseline, as compared to
ith FRS 4. BMI  body mass index.odeling) may be limited. Although these initial aesults are encouraging, they warrant further confir-
ation in larger studies, optimally with the use of
VUS and a detailed quantitative assessment of re-
odeling index.
Our results suggest that the rate of progression in
atients presenting to the emergency department with
cute chest pain over the course of 2 years is 12.7% for
ny plaque. Although we observed a large relative and
ignificant increase in noncalcified plaque at 2-year
ollow-up (3.1 5.8 baseline vs. 4.4 7.0 follow-up,
 0.04), the absolute change was similar between
alcified and noncalcified plaque. This observation is
n contrast to previous CT studies (3,9–12) on the
rogression of CAC in which the authors reported
rogression as high as 40% per year even in asymp-
omatic subjects. However, it is consistent with the
VUS study of Achenbach et al. (20), in which they
uggest that the plaques may undergo only minimal
hanges over time (1% per year atheroma volume
easured by IVUS). The discrepancy may be ex-
lained by the fact that most of CAC progression
tudies (22,26) have relied on CT imaging acquisition
echniques that have been shown to have significant
easurement variability.
In our study, the negative association between
laque progression and diabetes is likely a reflection
f the small number of diabetic patients within the
ohort (n  4). Similarly, the finding that current
tatin treatment was associated with plaque pro-
ression can be attributed to confounding by history
f CAD. However, our results suggest that subjects
ho had the greatest rates of plaque progression
top quartile) were re-evaluated for recurrent chest
ain more frequently during follow-up as compared
ith subjects in the bottom quartile of progression.
trengths and limitations. The baseline and
ollow-up CT scans were performed on the same
canner and adhered to a standard protocol. A
urther strength is the standardized assessment of
laque, including assessment of intraobserver and
nterobserver variability for both calcified and non-
alcified plaque. Furthermore, the study used a
ongitudinal regression model that enabled an as-
essment of progression accounting for baseline
laque burden and used prospectively collected
nformation on cardiovascular risk factors.
Our assessment is limited to the LM and the first
0 mm of the main coronary arteries. However,
apturing proximal plaque may be most relevant
ecause the majority of clinical events arise from
hese plaques (18). Although we used dedicated
oronary evaluation software, which permits theFollow-U
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1269he evaluation of each cross section remains time
onsuming (15 to 20 min per patient). Further
mprovements in coregistration and documentation
f assessments are necessary to enhance practicality.
In addition, our assessment does not capture
ross-sectional plaque extension such as area growth
r remodeling, which are important aspects of the
rogression of individual plaques. However, we
ound a robust correlation between volumetric pro-
ression and longitudinal semiquantitative assess-
ent (Pearson’s correlation coefficient 0.75;
 0.0001 for both absolute and relative change).
Finally, the present study describes the progres-
ion of atherosclerotic plaque stratified as calcified
nd noncalcified plaque. We omitted the category
f mixed plaque because plaques observed as calci-
ed on CT usually also contain noncalcified (fibrous
r lipid rich) components, which are not visualized
n CT because of the blooming effect of calcifica-
ion (27). Moreover, in the current analysis, we
etermined plaque progression on a cross section
ather than on a plaque basis.
linical implications. A reliable noninvasive method
o serially evaluate both calcified and noncalcified
laque provides a unique opportunity to validate
laque progression as a surrogate marker for the
ssessment of cardiovascular risk and most impor-
antly for the effect of medical therapies for cardio-
ascular disease. The ability to detect progression of
oncalcified plaque warrants further assessment and
alidation, especially as a potential surrogate marker
or the effects of medical therapy.
O N C L U S I O N S
oronary plaque burden of patients with acuteet al. Statins, high-density lipopro-
6. Takagi T, Yoshid
Hozumi T, Moriokf 2 years, but rate of progression is dependent on
laque composition and may be greater for noncal-
ified compared with calcified plaque. Progression
s further associated with cardiovascular risk profile
t baseline. Larger studies are needed to confirm
hese results and to determine effect of medical
reatment on progression.
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